H.I.G. Capital

H.I.G. Capital, LLC, established in 1993 and headquartered in Miami, Florida, is a global private equity firm specializing in providing capital and operational support to small and medium-sized companies. The firm invests in various sectors, including business services, consumer goods, healthcare, industrials, and technology, with a focus on the United States, Europe, and Latin America. H.I.G. Capital typically invests between $3 million and $100 million in companies with enterprise values ranging from $25 million to $1 billion, offering both debt and equity capital. The firm's investment strategy includes leveraged buyouts, growth equity, and recapitalizations, aiming to support undermanaged or underperforming companies through operational improvements and strategic growth initiatives.

Olivier Boyadjian

President

Kevin Van Culin

Managing Director

Matt Gullen

Managing Director

Ross Hiatt

Co-Head, Managing Director, H.I.G. Growth Partners

Ryan Kaplan

Managing Director

Nishant Nayyar

Managing Director, European Middle Market

Markus Noe-Nordberg

Managing Director and Head, European Middle Market Fund

Keval Patel

Managing Director, Head of H.I.G. US Middle Market and Head of North American Chemicals

Christian Kraul-von Renner

Director

Matthew Robinson

Managing Director, Advantage Fund

Schwartz, Brian M.

Co-President

Aaron Tolson

Managing Director

Andrey Vakhovskiy

Managing Director

Rahul Vinnakota

Managing Director

Rob Wolfson

Managing Director

Alex Zisson

Managing Director

Past deals in Illinois

SkinCure Oncology

Acquisition in 2024
SkinCure Oncology LLC, founded in 2016 and based in Chicago, Illinois, specializes in dermatology services, focusing on a non-invasive approach to skin cancer treatment. The company offers a support system that dermatologists trust for superficial radiation therapy (SRT), specifically designed for non-melanoma skin cancers. Utilizing advanced technology, SkinCure Oncology provides a method that allows physicians to deliver effective radiation therapy in their offices, avoiding the negative side effects commonly associated with invasive treatments. This innovative approach aims to enhance patient care while making effective skin cancer treatment more accessible.

On Target Laboratories

Series C in 2023
On Target Laboratories, LLC engages in discovering, developing, and commercializing small molecules that target specific pathological cells, when conjugated with fluorescent dyes. It offers folate and other targeting agents that target, lung, uterine, kidney, breast, colon, pancreatic, and prostate cancer cells. The company was incorporated in 2010 and is based in Northbrook, Illinois.

Augmedics

Series D in 2023
Augmedics Ltd. is a company that specializes in augmented reality surgical guidance systems, aiming to enhance the safety and effectiveness of surgical procedures. Founded in 2014 and headquartered in Yoqneam Ilit, Israel, with an additional office in Chicago, Illinois, the company has developed the xvision-spine (XVS) system. This innovative system features a head-mounted display that allows surgeons to visualize a patient's anatomy through skin and tissue, providing real-time insights into the position of surgical tools and illuminating the surgical area. By integrating advanced technologies, Augmedics seeks to transform surgical treatment and improve patient outcomes during complex operations.

Watchfire Signs

Acquisition in 2022
Watchfire Signs, LLC is a manufacturer based in Danville, Illinois, specializing in the design, production, and servicing of durable LED signs and digital billboards. Founded in 1932, the company offers a wide range of products, including outdoor and indoor sports video scoreboards, fixed digit scoreboards, indoor displays, and gas price displays. Additionally, Watchfire provides digital sign software, installation services, and in-house engineering and support. Its products cater to various sectors, including communities, commercial clients, entertainment, and digital outdoor advertising. Watchfire Signs operates through a network of dealers, helping businesses effectively communicate with their audience and enhance visibility. The company was previously known as Time-O-Matic Inc. and is a subsidiary of The Jordan Company, L.P.

Clarus Therapeutics

Post in 2021
Clarus Therapeutics is a men's health specialty pharmaceutical company based in Northbrook, Illinois, founded in 2003. The company specializes in the development and commercialization of oral testosterone replacement therapies in the United States. Its primary product, JATENZO, is a soft gel formulation of testosterone undecanoate, designed to treat men with low testosterone levels, also known as hypogonadism. JATENZO is notable for being the first and only oral testosterone replacement therapy available, serving as the sole source of revenue for Clarus Therapeutics. In addition to JATENZO, the company is also engaged in the development of other androgen-based medications for both men and women.

Augmedics

Series C in 2021
Augmedics Ltd. is a company that specializes in augmented reality surgical guidance systems, aiming to enhance the safety and effectiveness of surgical procedures. Founded in 2014 and headquartered in Yoqneam Ilit, Israel, with an additional office in Chicago, Illinois, the company has developed the xvision-spine (XVS) system. This innovative system features a head-mounted display that allows surgeons to visualize a patient's anatomy through skin and tissue, providing real-time insights into the position of surgical tools and illuminating the surgical area. By integrating advanced technologies, Augmedics seeks to transform surgical treatment and improve patient outcomes during complex operations.

On Target Laboratories

Series B in 2021
On Target Laboratories, LLC engages in discovering, developing, and commercializing small molecules that target specific pathological cells, when conjugated with fluorescent dyes. It offers folate and other targeting agents that target, lung, uterine, kidney, breast, colon, pancreatic, and prostate cancer cells. The company was incorporated in 2010 and is based in Northbrook, Illinois.

Vantage Specialty Chemicals

Acquisition in 2017
Vantage Specialty Chemicals, Inc. is a manufacturer of naturally derived specialty chemicals and ingredients, primarily serving the personal care, food, consumer, and industrial markets. The company operates through four distinct business units: Vantage Personal Care, Vantage Performance Materials, Vantage Oleochemicals, and Vantage Food. Its Personal Care unit supplies chemical ingredients for various cosmetic products, while the Performance Materials unit focuses on chemicals for applications in oil and gas, lubricants, and precision cleaning. The Oleochemicals unit produces fatty acids and glycerin utilized in everyday products, and the Food unit offers processing aids and equipment. Vantage specializes in the derivatization of fatty acids through alkoxylation and esterification, creating products such as surfactants, emulsifiers, and performance additives. With a strong technical expertise and flexible processes, Vantage serves a wide range of industries, including agriculture, pharmaceuticals, textiles, and water treatment, while maintaining a global presence with locations in multiple countries. The company was incorporated in 2008 and is headquartered in Chicago, Illinois.

Empire Today

Acquisition in 2016
Empire Today, LLC is a prominent shop-at-home company that specializes in providing installed flooring products to residential and business customers throughout the United States. Founded in 1959 and based in Northlake, Illinois, the company offers a wide range of products, including carpet, hardwood, laminate, luxury vinyl, vinyl, tile, and window treatments. It operates in 68 markets, covering many of the largest metropolitan areas in the country, and employs sales representatives to facilitate direct consultations and installations. Empire Today was formerly known as Empire Home Services, LLC, having rebranded in May 2007. The company's focus on customer convenience and a comprehensive selection of flooring solutions has established it as one of the largest specialty flooring providers in America.

Clarus Therapeutics

Series C in 2007
Clarus Therapeutics is a men's health specialty pharmaceutical company based in Northbrook, Illinois, founded in 2003. The company specializes in the development and commercialization of oral testosterone replacement therapies in the United States. Its primary product, JATENZO, is a soft gel formulation of testosterone undecanoate, designed to treat men with low testosterone levels, also known as hypogonadism. JATENZO is notable for being the first and only oral testosterone replacement therapy available, serving as the sole source of revenue for Clarus Therapeutics. In addition to JATENZO, the company is also engaged in the development of other androgen-based medications for both men and women.

CellIT

Venture Round in 2000
Cellit is a marketing and advertising company that specializes in mobile marketing solutions, offering services such as text message advertising and mobile surveys. Founded in March 2012 and based in Illinois, Cellit focuses on enhancing customer interaction management by combining customer service and marketing expertise with engineering capabilities. The company develops innovative mobile platforms and custom technologies designed to engage and mobilize customer bases effectively. Cellit has been acquired by HelloWorld, which provides a comprehensive SaaS platform for the advertising market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.